Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment

The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
Hans-Jürgen Möller

Abstract

It is increasingly recognised that major depressive disorder can be a chronic condition with many patients experiencing recurrent episodes. Remission from a depressive episode implies the absence or near absence of depressive symptoms. However, for many patients the periods between depressive episodes are not symptom free. Residual symptoms are predictors of relapse or recurrence, and may be associated with residual psychosocial impairment. In clinical studies, remission is commonly defined using a cut-off score on a rating scale for depressive symptoms, such as a score of < or = 7 on the 17-item Hamilton scale. However, there is debate about which scales and cut-offs are optimal and full-length rating scales are not widely used in clinical practice. In spite of such issues, it seems clear that a therapy should aim at the most complete remission possible. Unfortunately, recent studies have highlighted that in clinical practice usually only a low rate of remission is achieved. Although long-term treatment with antidepressants can reduce the risk of relapse or recurrence only a minority of patients in clinical practice achieve this as treatment is often prematurely stopped due to long-term side effects such as sleep disturbance, ...Continue Reading

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Oct 1, 1992·Archives of General Psychiatry·J MintzS S Hwang
May 1, 1986·Psychiatry Research·A J RushC Burns
Nov 1, 1995·Psychological Medicine·E S PaykelA Barocka
May 1, 1996·Psychological Medicine·A J RushM H Trivedi
May 26, 1997·Archives of Internal Medicine·J L CoulehanE Rodriguez
Jun 1, 1997·The Journal of Clinical Psychiatry·M Y AğargünM Solmaz
Nov 21, 1997·Archives of General Psychiatry·D A SolomonJ Endicott
Apr 29, 1998·Harvard Review of Psychiatry·A C VigueraJ Friedberg
Jun 12, 1998·JAMA : the Journal of the American Medical Association·B W PenninxR B Wallace
Oct 2, 1998·Archives of Family Medicine·E H LinE Ludman
Apr 30, 1999·The Journal of Clinical Psychiatry·A A NierenbergM Fava
Feb 15, 2000·The American Journal of Psychiatry·D A SolomonJ Endicott
Mar 4, 2000·Journal of Psychiatric Research·D FariesW Z Potter
Apr 18, 2000·Archives of General Psychiatry·L L JuddM B Keller
Jun 28, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·D Hinze-SelchT Pollmächer
Dec 16, 2000·The British Journal of Psychiatry : the Journal of Mental Science·T A FurukawaK Takahashi
Jan 6, 2001·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·R Armitage
Feb 15, 2001·Journal of Affective Disorders·D J Kupfer, E Frank
Mar 16, 2001·Expert Opinion on Pharmacotherapy·P S Masand
Apr 13, 2001·Journal of the American Geriatrics Society·S L Kivelä, K Pahkala
Jul 5, 2001·The Australian and New Zealand Journal of Psychiatry·G S MalhiI Caterson
Jul 17, 2001·Biological Psychology·D RiemannU Voderholzer
Aug 4, 2001·Psychosomatic Medicine·M de GrootP J Lustman
Sep 25, 2001·Depression and Anxiety·A WinokurM P Szuba
Oct 2, 2001·The American Journal of Psychiatry·R Mojtabai

❮ Previous
Next ❯

Citations

Jul 7, 2011·The Primary Care Companion to CNS Disorders·Wayne Katon, Christine J Guico-Pabia
Oct 22, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Cheng-Ta LiTung-Ping Su
Jul 4, 2009·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Hans-Jürgen Möller
Mar 4, 2009·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Siegfried Kasper, Michel Hamon
Mar 12, 2009·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Gabriel Manjarrez-GutierrezJorge Hernandez-R
Dec 16, 2009·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Yasuhiro Kaneda
Jul 30, 2008·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Hans-Jürgen Möller
Apr 10, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Sheung-Tak ChengTimothy Kwok
Aug 21, 2012·Comprehensive Psychiatry·Mark ZimmermanDaniela A Boerescu
Nov 29, 2011·European Psychiatry : the Journal of the Association of European Psychiatrists·H-J MöllerUNKNOWN European Psychiatric Association
Sep 13, 2011·Journal of Psychiatric Research·Jorge Mota-PereiraJoaquim Ramos
May 4, 2011·International Journal of Methods in Psychiatric Research·André Russowsky Brunoni, Felipe Fregni
Apr 28, 2010·Expert Review of Neurotherapeutics·William V Bobo, Richard C Shelton
Jul 12, 2014·Journal of Affective Disorders·Jean EndicottChristine J Guico-Pabia
Sep 26, 2013·The International Journal of Neuropsychopharmacology·Brian DeanMark J Millan
May 22, 2016·BMC Psychiatry·Florian SeemüllerHans-Jürgen Möller
Aug 3, 2010·Pharmaceuticals·Joshua A Israel
Dec 12, 2018·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Alkomiet HasanUNKNOWN WFSBP Guideline Task Force Chairs
Oct 28, 2009·Der Nervenarzt
Apr 13, 2018·Clinical Practice and Epidemiology in Mental Health : CP & EMH·Veronica VitriolSoledad Potthoff
Jul 16, 2013·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Chiara FabbriAlessandro Serretti
Apr 2, 2014·Journal of Cardiovascular Medicine·Rossella Di StefanoAlberto Balbarini
Dec 12, 2019·The Australian and New Zealand Journal of Psychiatry·Adrien RigalEmmanuelle Corruble
May 28, 2013·CNS Drugs·Changsu HanChi-Un Pae
Aug 30, 2017·Frontiers in Molecular Neuroscience·Mylène HervéEl Chérif Ibrahim
Oct 13, 2017·The International Journal of Neuropsychopharmacology·Oloruntoba J OlubokaPierre Blier
Oct 23, 2020·Psychological Medicine·Romain ColleEmmanuelle Corruble

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.